You are here

Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference

LAVAL, Quebec, Jan. 13, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (the "Company") has published a brief company update presentation designed to complement remarks that will be provided by management during a fireside chat at 1:30 p.m. PT (4:30 p.m. ET) today during the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation provides an overview of the Company's recent performance and achievements, including updates on the Company's 2019 commitments and development programs, and offers insight into future goals and catalysts for 2020 and beyond.

The presentation is available on the Investor Relations page of the Bausch Health Companies Inc. web site at: https://ir.bauschhealth.com/events-and-presentations/2020. A live webcast and audio archive of the fireside chat will also be available on the Investor Relations page of the Company's web site.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of Bausch Health management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Bausch Health's most recent annual or quarterly report and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com

lainie.keller@bauschhealth.com

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-publishes-company-update-for-the-38th-annual-jp-morgan-healthcare-conference-300985310.html

SOURCE Bausch Health Companies Inc.